Bendroflumethiazide / Nadolol Oral Tablet

Brand(s)
Corzide
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Pfizer Laboratories Div Pfizer Inc (2014-05-20)
Oldest Current Product
1983-05-25
License(s)
NDA, ANDA
RxNORM
ORAL TABLET\BENDROFLUMETHIAZIDE:NADOLOL
FDAOB
ORAL\TABLET\BENDROFLUMETHIAZIDE: NADOLOL
SPL Active
ORAL\TABLET\BENDROFLUMETHIAZIDE: NADOLOL
SPL Moiety
ORAL\TABLET\BENDROFLUMETHIAZIDE: NADOLOL

product(s) by strength(s)

bendroflumethiazide 5 mg / nadolol 40 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1607930283CorzideNDAPfizer Laboratories Div Pfizer Inc1983-05-25BENDROFLUMETHIAZIDE, NADOLOLORALTABLETNDA0186473f11df27-710b-4903-a985-74ee4674a844

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1001155311ANDAGlobal Pharmaceuticals2007-03-30BENDROFLUMETHIAZIDE, NADOLOLORALTABLETANDA077833d2d226ea-1624-47ee-82bf-e9660b75029f

bendroflumethiazide 5 mg / nadolol 80 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1607930284CorzideNDAPfizer Laboratories Div Pfizer Inc1983-05-25BENDROFLUMETHIAZIDE, NADOLOLORALTABLETNDA0186473f11df27-710b-4903-a985-74ee4674a844

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1001155322ANDAGlobal Pharmaceuticals2007-03-30BENDROFLUMETHIAZIDE, NADOLOLORALTABLETANDA077833d2d226ea-1624-47ee-82bf-e9660b75029f

application(s)

#idtitleapplicantapprovedapproved drug
1ANDA077833NADOLOL AND BENDROFLUMETHIAZIDEIMPAX LABORATORIES INC2007-03-30ANDA077833_001, ANDA077833_002
2ANDA078688NADOLOL AND BENDROFLUMETHIAZIDEMYLAN PHARMACEUTICALS INC2008-02-15ANDA078688_001, ANDA078688_002
3NDA018647CORZIDEKING PHARMACEUTICALS INC1983-05-25NDA018647_001, NDA018647_002

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldTEapprovedapplication
1ANDA077833_001RXBENDROFLUMETHIAZIDE (5MG), NADOLOL (40MG)ORALTABLETFalseAB2007-03-30NADOLOL AND BENDROFLUMETHIAZIDE
2ANDA077833_002RXNADOLOL (80MG), BENDROFLUMETHIAZIDE (5MG)ORALTABLETFalseAB2007-03-30NADOLOL AND BENDROFLUMETHIAZIDE
3ANDA078688_001RXNADOLOL (40MG), BENDROFLUMETHIAZIDE (5MG)ORALTABLETFalseAB2008-02-15NADOLOL AND BENDROFLUMETHIAZIDE
4ANDA078688_002RXBENDROFLUMETHIAZIDE (5MG), NADOLOL (80MG)ORALTABLETFalseAB2008-02-15NADOLOL AND BENDROFLUMETHIAZIDE
5NDA018647_001RXNADOLOL (40MG), BENDROFLUMETHIAZIDE (5MG)ORALTABLETFalseAB1983-05-25CORZIDE
6NDA018647_002RXNADOLOL (80MG), BENDROFLUMETHIAZIDE (5MG)ORALTABLETTrueAB1983-05-25CORZIDE

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
13f11df27-710b-4903-a985-74ee4674a844 (view SPL)CORZIDE (nadolol and bendroflumethiazide tablets)prescriptionHuman PrescriptionPfizer Laboratories Div Pfizer IncANALYSIS, LABEL, MANUFACTURE, PACK2014-05-208607930283, 607930284
2d2d226ea-1624-47ee-82bf-e9660b75029f (view SPL)NADOLOL AND BENDROFLUMETHIAZIDE TABLETS, USP, 40 mg/5 mg AND 80 mg/5 mgprescriptionHuman PrescriptionGlobal PharmaceuticalsREPACK2013-10-234001155311, 001155322

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII